CIK 0000873303 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2022 | FY2021 | |
|---|---|---|---|---|
| Revenue (USD) | 2.2 B | 933.0 M | ||
| Net income (USD) | -554.1 M | -715.1 M | ||
| Diluted EPS (USD/shares) | -7.13 | -8.03 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-09-23 | 8-K | 8-K items 1.01 | 2026-09-23 |
| 2026-09-08 | 4 | 4 | 2026-09-04 |
| 2026-09-08 | 4 | 4 | 2026-09-04 |
| 2026-09-08 | 4 | 4 | 2026-09-04 |
| 2026-09-08 | 4 | 4 | 2026-09-04 |
| 2026-08-14 | 13F-HR | 13F-HR | 2026-06-30 |
| 2026-08-13 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-07 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-08-05 | 8-K | 8-K items 2.02,9.01 | 2026-08-05 |
| 2026-08-05 | 10-Q | 10-Q | 2026-06-30 |
| 2026-07-31 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-30 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-07-29 | 4 | 4 | 2026-07-28 |
| 2026-07-29 | 3 | 3 | 2026-07-28 |
| 2026-07-28 | S-8 | S-8 | |
| 2026-07-27 | 8-K | 8-K items 5.02,7.01,9.01 | 2026-07-23 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-05 | 4 | 4 | 2026-06-04 |
| 2026-06-04 | S-8 | S-8 |
Forms on file (last 1,000): 4 444, 8-K 200, SC 13G/A 56, 10-Q 47, 3 36, SC 13G 22, 424B5 22, 144 17. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SRPT (0.002 USD), /gw/filings/filings?ticker=SRPT&form=8-K, /gw/filings/facts?ticker=SRPT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange